Advertisement

Topics

Latest "Confarma France S.A.R.L" News Stories

15:11 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "Confarma France S.A.R.L" found in our extensive news archives from over 250 global news sources.

More Information about Confarma France S.A.R.L on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Confarma France S.A.R.L for you to read. Along with our medical data and news we also list Confarma France S.A.R.L Clinical Trials, which are updated daily. BioPortfolio also has a large database of Confarma France S.A.R.L Companies for you to search.

Showing "Confarma France" News Articles 1–25 of 2,300+

Thursday 13th December 2018

French National Institute of Health and Medical Research Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryFrench National Institute of Health and Medical Research INSERM is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immunology, inflammation, genetics, cancer, infectiology and microbiology, physiopathology, public health, ...


AB Science SA AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryAB Science SA ABS is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including cKit, PDGFR, and Lyn in several human indications such as oncology, inflammatory diseases, and central nervous system...

Pixium Vision awarded Galien Prize 2018 for research with PRIMA system

Pixium Vision awarded Galien Prize 2018 for research with PRIMA system for dry AMD Paris, France - December 13, 2018 - 7 AM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today that it has been awarded the Prix Galien 2018 in the &qu...


Wednesday 12th December 2018

Stream Bio launches new range of Streptavidin-linked CPNs

Stream Bio, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has launched its new range of Streptavidin-linked CPNs™ onto the market. These Streptavidin Conjugates can be used for the detection of various biomolecules and will complement Stream’s current portfolio of CPN™ molecular probes. Stream Bio’s CPNs™ have applicati...

Tumor cells conquer territory from their neighbors using a newly discovered mechanism

(Champalimaud Centre for the Unknown) How do tumoral cells replace healthy cells to promote tumor progression? Scientists from the Institut Pasteur (Paris, France) and from the Champalimaud Centre for the Unknown (Lisbon, Portugal) identified a mechanism that responds to cell deformation and can be exploited by tumoral cells to squeeze out and kill their neighbors. This mechanism may promote the e...

Luye Pharma's Global Strategy For CNS-Focused Products Gathers Pace: Rotigotine Extended Release Microspheres Submitted to Japan's PMDA for Clinical Trial Approval

SHANGHAI, Dec. 12, 2018 /PRNewswire/ -- Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003) for the treatment of Parkinson's disease has been submitted to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for clinical trial approval. Meanwhile Phase III clinical trials for LY03003 in the U.S. and China are progressi...

Myriad Genetics Inc MYGN Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryMyriad Genetics Inc Myriad is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company's product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later ...

Boehringer reshuffle cuts 327 jobs in France

Boehringer says it will reduce its workforce in France, including 182 positions in human health, to streamline operations in âdeteriorating marketsâ.

Boehringer plans to cut 300 jobs in France

The reductions are tied to ongoing integration of Boehringer's Merial animal health unit as well as competitive challenges in human health, the Germany drugmaker said.

Atopic dermatitis market set to almost triple in value over next 10 years

The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData. The market is expected to grow from $6.4 billion in 2017 to a value of $18.3 billion in 2027 across seven major markets at a compound annual growth rate of 11.1%, as the drive to meet high levels of unmet need fuels growth. The seven major markets include the US, France, German...

UrgoNight Can Train Your Brain To Sleep Better

French start-up firm Urgo Tech will soon be offering consumers in the US, France and UK a way to use...    

First production and administration of Axumin▼® (fluciclovine (18F)) in France.

Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the first commercial production of Axumin® (fluciclovine (18F)) in France occurred recently, with the first French patients being dosed. Axumin is a novel molecular imaging agent approved in the European Union for use in PET imaging to detect and localize ...

Global atopic dermatitis market set to reach $18.3 billion by 2027

The atopic dermatitis market is expected to grow from $6.4 billion in 2017 to $18.3 billin in 2027 across the seven major markets (US, France, Germany, Italy, Spain, the UK and Japan) at a compound annual growth rate (CAGR) of 11.1%

DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018

Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated immune profile of healthy human skin in different body sites Findings support application of epicutaneous immunotherapy (EPIT) to int

2018 Seoul International Invention Fair: Majority of Awards Given to Safety and Hygiene Inventions

- 606 inventions from 33 countries, including France and the U.S.A. -10 grand prize winners with one invention related to oral antibiotics SEOUL, South Korea, Read more...

Tuesday 11th December 2018

France Respiratory Devices Market Outlook to 2025 [Report Updated: 12102018] Prices from USD $4246

France Respiratory Devices Market Outlook to 2025SummaryGlobalData's new report, France Respiratory Devices Market Outlook to 2025, provides key market data on the France Respiratory Devices market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Humidifiers, Nebulizers, NonInvasive Ventilation Masks Circuits, Oxygen Concentrato...

Following Sanofi Cuts Last Week, Boehringer Ingelheim to Cut 327 Jobs in France

More pharma workers in France are receiving coal in their stockings this year after Germany-based Boehringer Ingelheim announced plans to cut about 300 jobs in that country as part of a reorganization of its operations in France.

France Neuromodulation Procedures Outlook to 2025 [Report Updated: 15112018] Prices from USD $2546

France Neuromodulation Procedures Outlook to 2025SummaryGlobalData's new report, France Neuromodulation Procedures Outlook to 2025, provides key procedures data on the France Neuromodulation Procedures. The report provides procedure volumes within market segments Deep Brain Stimulators Procedures, Gastric Electric Stimulators Procedures, Peripheral Nerve Stimulators Procedures, Sacral Nerve Stimu...

Mobidiag Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryMobidiag Ltd Mobidiag is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Proveit. Its Amplidiag is a diagnostic test for highvolume screening of gastrointestinal pathogens and antibiotic resistances. Mobidiag's Proveit products include proveit sepsis, proveit bone...

France Dental Implants Market Outlook to 2025 [Report Updated: 01092018] Prices from USD $4246

France Dental Implants Market Outlook to 2025SummaryGlobalData's new report, France Dental Implants Market Outlook to 2025, provides key market data on the France Dental Implants market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Titanium Dental Implants and Zirconium Dental Implants.The report also provides company shares a...

.@Boehringer's #France restructure will cull over 300 #jobs http://bit.ly/2UG9X7s  #pharma

. @Boehringer's #France restructure will cull over 300 #jobs http://bit.ly/2UG9X7s  #pharma

Boehringer cuts nearly 300 jobs in France

The company's French workforce will see 327 jobs cut but will also 32 new ones created.

Amatsigroup SAS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryAmatsigroup SAS Amatsigroup is a contract development manufacturing organization that offers human and veterinary pharmaceutical development through preclinical and clinical phases. The organization provides services such as bioservices, clinical trial supply, formulation development and manufacturing, management of drug product development and pharmaceutical analysis solutions, among other...

Calixar SAS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryCalixar SAS Calixar is a provider of solutions to develop conformational antibodies. The company offers production, Solubilization, extraction, purification, stabilization and crystallization of functional membrane proteins and antigens. It offers technology to discover and validate the potential of new target antigens. Calixar's technology also helps to produce immunogenic and native membr...

Valbiotis SAS ALVAL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryValbiotis SAS Valbiotis is a biotechnology company that develops novel solutions to help prevent cardiometabolic diseases, besides nutrition products. It develops solutions to prevent type 2 diabetes, nonalcoholic steatohepatitis NASH, obesity and cardiovascular diseases. The company has three products under development based on the active ingredient TOTUM63. They include Valedia, indicated...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks